New York, NY. Nixon Peabody LLP represented Millar Holdings, Inc., in its sale to CTS Corporation (NYSE: CTS).
On October 23, 2026, CTS announced that it completed the acquisition of Millar. Millar is a leading developer and manufacturer of high-performance sensing technologies and custom sensor-integrated solutions for medical devices, life sciences, and industrial applications. With operations across North America, Europe, and Asia, CTS pairs deep engineering capabilities with global manufacturing scale to deliver highly engineered solutions for critical, high-performance applications in diverse end markets.
“We are proud to have represented Millar in this important transaction,” Nixon Peabody partner Kevin Grant, leader of the firm’s M&A and Corporate Transactions team, who led Nixon Peabody’s deal team. “Millar has built an impressive platform and reputation over the past more than 55 years, and this combination with CTS creates exciting opportunities for continued innovation and growth.”
In addition to Grant, the Nixon Peabody team included partner and M&A and Corporate Transactions team deputy leader Daniel Belostock, partner Nicholas Gerlach, counsel Lisa Perri, and associates Kadeem Apply and Emily Morrison.
For additional information on this deal, please see CTS’s press release: CTS Acquires Millar Holdings.
